Why Omnicell Stock Trounced the Market on Tuesday

Omnicell (NASDAQ: OMCL) is off to a roaring start this year, at least as far as its quarterly performance is concerned. On Tuesday, it published its first earnings report of the year, and Mr. Market greeted this very positively. Investors couldn't get their hands on the healthcare tech stock fast enough, and they powered to a nearly 21% gain that day. Omnicell's revenue rose by almost 15% year-over-year to a shade under $310 million that quarter. That handily beat the consensus analyst estimate of barely over $304 million. Both product and service revenue grew during the period, with the former advancing a robust 20% to nearly $175 million, and the latter increasing 8% to $135 million. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool